Greenwich LifeSciences (GLSI) Current Assets (2019 - 2026)

Greenwich LifeSciences (GLSI) has 5 years of Current Assets data on file, last reported at $6.2 million in Q4 2025.

• Quarterly Current Assets rose 50.98% year-over-year to $6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.2 million (up 50.98% YoY) and the FY2025 annual result came in at $6.2 million, up 50.98% from the prior year.
• Current Assets advanced to $6.2 million in Q4 2025, from $4.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $30.4 million in Q1 2021 to a low of $4.1 million in Q4 2024.
• A 3-year average of $19.9 million and a median of $28.9 million in 2021 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2021 — Current Assets surged 361.98% — and 2025, when it surged 50.98%.
• Tracing GLSI's Current Assets over 3 years: stood at $28.9 million in 2021, then sank by 85.84% to $4.1 million in 2024, then jumped by 50.98% to $6.2 million in 2025.
• The last three Current Assets figures came in at $6.2 million (Q4 2025), $4.1 million (Q4 2024), and $28.9 million (Q3 2021), per Business Quant data.